Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Blanchard JJ, Kring AM, Horan WP, Gur R.

Schizophr Bull. 2011 Mar;37(2):291-9. doi: 10.1093/schbul/sbq104. Epub 2010 Sep 22.

2.

Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ.

Schizophr Res. 2011 Nov;132(2-3):140-5. doi: 10.1016/j.schres.2011.06.030. Epub 2011 Jul 27.

3.

Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).

Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R.

Schizophr Res. 2010 Dec;124(1-3):36-42. doi: 10.1016/j.schres.2010.08.039. Epub 2010 Sep 24.

4.

The brief negative symptom scale: psychometric properties.

Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR.

Schizophr Bull. 2011 Mar;37(2):300-5. doi: 10.1093/schbul/sbq059. Epub 2010 Jun 17.

5.

Food and Drug Administration commentary on methodological issues in negative symptom trials.

Laughren T, Levin R.

Schizophr Bull. 2011 Mar;37(2):255-6. doi: 10.1093/schbul/sbq162. Epub 2011 Jan 18. No abstract available.

6.

The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP.

Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.

7.

Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Engel M, Fritzsche A, Lincoln TM.

Psychiatry Res. 2014 Dec 15;220(1-2):659-63. doi: 10.1016/j.psychres.2014.07.070. Epub 2014 Aug 1.

PMID:
25138895
8.

Methodological issues in negative symptom trials.

Marder SR, Daniel DG, Alphs L, Awad AG, Keefe RS.

Schizophr Bull. 2011 Mar;37(2):250-4. doi: 10.1093/schbul/sbq161. Epub 2011 Jan 26.

9.

Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop.

Bellack AS, Green MF, Cook JA, Fenton W, Harvey PD, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, Patterson TL, Rose A, Stover E, Wykes T.

Schizophr Bull. 2007 May;33(3):805-22. Epub 2006 Aug 24.

10.

Alexithymia and schizophrenias.

Stanghellini G, Ricca V.

Psychopathology. 1995;28(5):263-72.

PMID:
8559950
11.

Defining and measuring negative symptoms of schizophrenia in clinical trials.

Marder SR, Kirkpatrick B.

Eur Neuropsychopharmacol. 2014 May;24(5):737-43. doi: 10.1016/j.euroneuro.2013.10.016. Epub 2013 Nov 11. Review.

PMID:
24275698
12.

Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).

Valiente-Gómez A, Mezquida G, Romaguera A, Vilardebò I, Andrés H, Granados B, Larrubia J, Pomarol-Clotet E, McKenna PJ, Sarró S, Bernardo M.

Schizophr Res. 2015 Aug;166(1-3):104-9. doi: 10.1016/j.schres.2015.06.006. Epub 2015 Jun 23.

PMID:
26116328
13.

Issues in selection of instruments to measure negative symptoms.

Daniel DG.

Schizophr Res. 2013 Nov;150(2-3):343-5. doi: 10.1016/j.schres.2013.07.005. Epub 2013 Jul 27. Review.

14.

Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.

Keefe RS, Harvey PD, Lenzenweger MF, Davidson M, Apter SH, Schmeidler J, Mohs RC, Davis KL.

Psychiatry Res. 1992 Nov;44(2):153-65.

PMID:
1480680
15.

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW.

Schizophr Bull. 2003;29(4):703-15. Erratum in: Schizophr Bull. 2004;30(2):following 217.

PMID:
14989408
16.

Computerized measurement of negative symptoms in schizophrenia.

Cohen AS, Alpert M, Nienow TM, Dinzeo TJ, Docherty NM.

J Psychiatr Res. 2008 Aug;42(10):827-36. Epub 2007 Oct 24.

17.

Assessment of enduring deficit and negative symptom subtypes in schizophrenia.

Mueser KT, Douglas MS, Bellack AS, Morrison RL.

Schizophr Bull. 1991;17(4):565-82.

PMID:
1805350
18.

The causal model of insight in schizophrenia based on the Positive and Negative Syndrome Scale factors and the structural equation modeling.

Hwang SS, Chang JS, Lee KY, Ahn YM, Kim YS.

J Nerv Ment Dis. 2009 Feb;197(2):79-84. doi: 10.1097/NMD.0b013e318196083e.

PMID:
19214041
19.

[Negative symptoms: clinical and psychometric aspects].

Adida M, Azorin JM, Belzeaux R, Fakra E.

Encephale. 2015 Dec;41(6 Suppl 1):6S15-7. doi: 10.1016/S0013-7006(16)30004-5. Review. French.

PMID:
26776385
20.

[Negative schizophrenic symptoms and their detection].

Kukla F, Gold R.

Fortschr Neurol Psychiatr. 1991 Feb;59(2):60-6. Review. German.

PMID:
2026379

Supplemental Content

Support Center